AMINO-LITE

Main information

  • Trade name:
  • AMINO-LITE 34X INJECTION CONCENTRATED AMINO ACIDS, WITH ELECTROLYTES AND B-VITAMIN SUPPLEMENT
  • Pharmaceutical form:
  • PARENTERAL LIQUID/SOLUTION/SUSPENSION
  • Units in package:
  • 500mL
  • Class:
  • Veterinary Medicine
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • AMINO-LITE 34X INJECTION CONCENTRATED AMINO ACIDS, WITH ELECTROLYTES AND B-VITAMIN SUPPLEMENT
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • CATTLE | HORSE | PIGS | SHEEP | BEEF | BOAR | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CALF | COLT | COW |
  • Therapeutic area:
  • amino acids,vitamins,elec
  • Therapeutic indications:
  • ANIMAL - DEBILITATED CONDITION | DIARRHOEA | VOMITING | ABSORPTIVE | ACUTE DIARRHOEA | ACUTE INTESTINAL CATARRH | AVIAN BLACKHEAD | BACTERIAL ENTERITIS | BLACKHEAD | CHRONIC DIARRHOEA | COCCIDIOSIS | DIETARY FACTORS | DIETARY UPSET | ENTERITIS | FEED CONVERSION | FLATULANCE | FLUID LOSS | GASTRO-INTESTINAL | GRAM NEGATIVE BACTERIA | GROWTH RATE | K88+ SEROTYPES OF E.COLI | NESTING DIARRHOEA | NON-SPECIFIC IRRITANTS | POISONING | POSTWEANING SCOURS | PROPHYLACTIC | SCOURS | STREPTOMYCIN SENSITIVE BACTERI | SULPHADIAZINE SENSITIVE BACTER | SULPHONAMIDE SENSITIVE BACTERI | TRICHOMONIASIS | TRIMETHOPRIM SENSITIVE BACTERI | WHITE SCOURS
  • Product summary:
  • For use as an aid in the treatment of debilitated animals, and supportive treatment in severe diarrhoea and vomiting, or after treatment or transporting.Nausea & distress may sometimes occur if this solution is administered too rapidly (refer label for details).

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Registered and available
  • Authorization number:
  • 35918/0198
  • Authorization date:
  • 28-01-1998
  • Last update:
  • 15-06-2017

Patient Information leaflet: composition, indications, side effects, dosage, interactions, adverse reactions, pregnancy, lactation

Page 1 of 1

6.1.98

ACTIVE CONSTITUENTS PER

100

mL:

L-HISTIDINE

HYDROCHLORIDE

MONOHYDRATE

34.0

mQ

L-hlETHlONlNE 34.0

mQ

L-TRYPTOPHANE 34.0

mg

L-CYSTEINE

HYDROCHLORIDE

MONOHYDRATE

S4.0

mQ

L-THREONINE 88.0

mg

L-ISOLEUCINE

68.0

“Q

L-ARGININE HYDROCHLORIDE 85.0

mg

L-PHENYLALANINE 102.0

mQ

L-VALINE 170.0

mS

L-LYSINE

MONOHYDROCHLORIDE 102.0

mg

L-LEUCINE 138.0

mg

L-GLUTAMINE

138.0

mg

VlTAMlN B, (AS RlEOFlAVlN S-PHOSPHATE SODIUM 8.0

mQ

VITAMIN

B,, 20.0

w

PYRIDOXINE HYDROCHLORIDE 20.0

mg

NlCOTlNAMlDE 225.0

mg

THIAMINE HYDROCHLORIDE (VITAMIN

B,

)

20.0

mS

DEXi-ROSE MONOHYDRATE 5.0

Q

CALCIUM CHLORIDE DIHYDRATE 15.0

mQ

POTASSILM CHLORIDE 20.0

mg

MAGNESIUM SULPHATE 40.0

mg

SODIWACETATE

151.0

mg

DISODIUM

EMnENEDlAMlNE

TETRA-ACETATE 15.0

mQ

3swo198

Store below

25°C

(Air Conditioning).

Protect from light. Refrigerate after opening. Do not

allow

to

freeze.

Batch No.:

Expiry

Date:

AMINO-LITE 34 X BOTTLE LABEL

KEEP OUT OF REACH OF CHILDREN

FOR ANIMAL TREATMENT ONLY

AMINO-LITE 34X INJECTION

Concentrated Amino Acids, with Electrolytes and

B-Vitamin

Supplement

For use as an aid in the treatment of debilitated

animals, and supportive treatment in severe

diarrhoea and vomiting, or after treatment or

transporting.

(Logo)

BOEHRINGER

INGELHEIM

N.R.A.

APPROVED LABEL

Dimctlona

for Use

VlTAMlN

B

CONTAINED IN THIS FORMULATION MAY BE

DETECTABLE IN BODY FLUIDS UP TO 48 HOURS AFTER

ADMINISTRATiON.

NAUSEA AND DISTRESS MAY

SOMETIMES

OCCUR IF THIS SOLUTION IS

ADMINISTERED

RAPIDLY.

SHOULD

THESE

SYMPTOMS

OCCUR,

DISCONTINUE

INJECTlON

UNTIL

ANIMAL

RETURNS

TO NORMAL. INJECTIONS MAY THEN

CONTfNUED

AT A

SLOWER RATE.

Amino Lite Injection

a sterile

solution and contains no

prsssrvativss.

Aseptic precautions should be observed in

handling. Use only sterik equipment.

For intramuscular, subcutaneous or intraperitoneal

cattls, sheep or swine and intravenous

drip

in horses only.

Suggested dose rate of 1

4.5kg

repeated

one to

three

times daily depending on severlty of condition.

Amino

Injection is only supportive in its action. Infectious

and pathological conditions should receive proper medicinal

treatment.

WlTHHOLDlNG

PERIOD NIL

Disposal

Dispose of empty container by wrapping in paper and putting in

garbage.

Diwibmdby

M-inch

Sdwhgu

InQahem Ply

Liiibd

Anhnd

Hnlltl

Diibn

SOBmughtmRoad

ARTARMON

N S W 2084

7-12-2018

Fine Land Corp Issues Allergy Alert on Undeclared Milk Allergens in “Meiqili Durian Candy”

Fine Land Corp Issues Allergy Alert on Undeclared Milk Allergens in “Meiqili Durian Candy”

Fine Land Corp is recalling it’s 12 ounce (340 g) Meiqili Durian Candy in plastic bag with clear window because it contains undeclared milk allergens. Consumers who are allergic to milk allergens may run the risk of serious or life – threatening allergic reactions if they consume this product.

FDA - U.S. Food and Drug Administration

18-6-2018

340 miljoen voor thuiswonende ouderen: zelfstandig oud worden in vertrouwde omgeving

340 miljoen voor thuiswonende ouderen: zelfstandig oud worden in vertrouwde omgeving

Ouderen willen het liefst in hun eigen vertrouwde omgeving zelfstandig oud worden en een fijn en zinvol leven leiden. Om dat beter mogelijk te maken presenteert minister De Jonge (VWS) vandaag het programma Langer Thuis. Het Kabinet investeert daar de komende jaren ruim 340 miljoen euro in. Het programma is vandaag door minister De Jonge en minister Ollongren (BZK) naar de Tweede Kamer gestuurd.

Netherlands - Ministerie van Volksgezondheid, Welzijn en Sport

10-1-2019


Orphan designation: glycine, L-alanine, L-arginine, L-aspartic acid, L-cysteine, L-cystine, L-glutamic acid, L-histidine, L-lysine monohydrate, L-methionine, L-phenylalanine, L-proline, L-serine, L-threonine, L-tryptophan, L-tyrosine, taurine, Treatment

Orphan designation: glycine, L-alanine, L-arginine, L-aspartic acid, L-cysteine, L-cystine, L-glutamic acid, L-histidine, L-lysine monohydrate, L-methionine, L-phenylalanine, L-proline, L-serine, L-threonine, L-tryptophan, L-tyrosine, taurine, Treatment

Orphan designation: glycine, L-alanine, L-arginine, L-aspartic acid, L-cysteine, L-cystine, L-glutamic acid, L-histidine, L-lysine monohydrate, L-methionine, L-phenylalanine, L-proline, L-serine, L-threonine, L-tryptophan, L-tyrosine, taurine, Treatment of maple syrup urine disease, 26/10/2018, Positive

Europe - EMA - European Medicines Agency

26-11-2018

Today #FDA announced the most significant modernization of the 510(k) medical device review process in a generation. https://www.wsj.com/articles/fda-is-revamping-clearance-procedures-for-medical-devices-1543234015 …

Today #FDA announced the most significant modernization of the 510(k) medical device review process in a generation. https://www.wsj.com/articles/fda-is-revamping-clearance-procedures-for-medical-devices-1543234015 …

Today #FDA announced the most significant modernization of the 510(k) medical device review process in a generation. https://www.wsj.com/articles/fda-is-revamping-clearance-procedures-for-medical-devices-1543234015 …

FDA - U.S. Food and Drug Administration

30-10-2018

EU/3/18/2076 (Orphan Europe S.A.R.L.)

EU/3/18/2076 (Orphan Europe S.A.R.L.)

EU/3/18/2076 (Active substance: Glycine, L-alanine, L-arginine, L-aspartic acid, L-cysteine, L-cystine, L-glutamic acid, L-histidine, L-lysine monohydrate, L-methionine, L-phenylalanine, L-proline, L-serine, L-threonine, L-tryptophan, L-tyrosine, taurine) - Orphan designation - Commission Decision (2018)7277 of Tue, 30 Oct 2018 European Medicines Agency (EMA) procedure number: EMA/OD/100/18

Europe -DG Health and Food Safety